Washington Eyecare Limited 09662476 false 2024-01-01 2024-12-31 2024-12-31 The principal activity of the company is that of an optician Digita Accounts Production Advanced 6.30.9574.0 true 09662476 2024-01-01 2024-12-31 09662476 2024-12-31 09662476 core:CurrentFinancialInstruments 2024-12-31 09662476 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 09662476 core:Non-currentFinancialInstruments core:AfterOneYear 2024-12-31 09662476 core:Goodwill 2024-12-31 09662476 core:FurnitureFittingsToolsEquipment 2024-12-31 09662476 core:OtherPropertyPlantEquipment 2024-12-31 09662476 bus:SmallEntities 2024-01-01 2024-12-31 09662476 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 09662476 bus:FilletedAccounts 2024-01-01 2024-12-31 09662476 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 09662476 bus:RegisteredOffice 2024-01-01 2024-12-31 09662476 bus:Director1 2024-01-01 2024-12-31 09662476 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 09662476 core:Goodwill 2024-01-01 2024-12-31 09662476 core:FurnitureFittings 2024-01-01 2024-12-31 09662476 core:FurnitureFittingsToolsEquipment 2024-01-01 2024-12-31 09662476 core:OfficeEquipment 2024-01-01 2024-12-31 09662476 core:OtherPropertyPlantEquipment 2024-01-01 2024-12-31 09662476 core:PlantMachinery 2024-01-01 2024-12-31 09662476 countries:EnglandWales 2024-01-01 2024-12-31 09662476 2023-12-31 09662476 core:Goodwill 2023-12-31 09662476 core:FurnitureFittingsToolsEquipment 2023-12-31 09662476 core:OtherPropertyPlantEquipment 2023-12-31 09662476 2023-01-01 2023-12-31 09662476 2023-12-31 09662476 core:CurrentFinancialInstruments 2023-12-31 09662476 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 09662476 core:Non-currentFinancialInstruments core:AfterOneYear 2023-12-31 09662476 core:FurnitureFittingsToolsEquipment 2023-12-31 09662476 core:OtherPropertyPlantEquipment 2023-12-31 iso4217:GBP xbrli:pure

Registration number: 09662476

Washington Eyecare Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 December 2024

 

Washington Eyecare Limited

Contents

Balance Sheet

1 to 2

Notes to the Unaudited Financial Statements

3 to 8

 

Washington Eyecare Limited

(Registration number: 09662476)
Balance Sheet as at 31 December 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

5

30,007

47,997

Current assets

 

Stocks

6

30,798

27,413

Debtors

7

17,297

24,630

Cash at bank and in hand

 

224,227

203,473

 

272,322

255,516

Creditors: Amounts falling due within one year

8

(149,209)

(108,591)

Net current assets

 

123,113

146,925

Total assets less current liabilities

 

153,120

194,922

Creditors: Amounts falling due after more than one year

8

(152,013)

(190,255)

Net assets

 

1,107

4,667

Capital and reserves

 

Called up share capital

50

60

Capital redemption reserve

(40)

-

Retained earnings

1,097

4,607

Shareholders' funds

 

1,107

4,667

 

Washington Eyecare Limited

(Registration number: 09662476)
Balance Sheet as at 31 December 2024

For the financial year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 28 May 2025
 

.........................................
Mr D Quinn
Director

 

Washington Eyecare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Washington Eyecare Limited
Unit 77 Albany Mall
The Galleries
Washington
Tyne & Wear
NE38 7SD

These financial statements were authorised for issue by the director on 28 May 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Washington Eyecare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Fixtures and fittings

20% Straight line

Office equipment

20% Straight line

Plant and machinery

33% straight line

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Goodwill

10% Straight line

 

Washington Eyecare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

 

Washington Eyecare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 8 (2023 - 9).

4

Intangible assets

Franchise
£

Total
£

Cost or valuation

At 1 January 2024

5,000

5,000

At 31 December 2024

5,000

5,000

Amortisation

At 1 January 2024

5,000

5,000

At 31 December 2024

5,000

5,000

Carrying amount

At 31 December 2024

-

-

5

Tangible assets

Furniture, fittings and equipment
 £

Computer equipment
£

Total
£

Cost or valuation

At 1 January 2024

343,228

21,839

365,067

Additions

4,255

291

4,546

At 31 December 2024

347,483

22,130

369,613

Depreciation

At 1 January 2024

302,052

15,018

317,070

Charge for the year

19,080

3,456

22,536

At 31 December 2024

321,132

18,474

339,606

Carrying amount

At 31 December 2024

26,351

3,656

30,007

At 31 December 2023

41,176

6,821

47,997

 

Washington Eyecare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

6

Stocks

2024
£

2023
£

Finished goods and goods for resale

30,798

27,413

7

Debtors

Current

Note

2024
£

2023
£

Trade debtors

 

8,693

12,907

Amounts owed by related parties

672

672

Prepayments

 

7,818

11,051

Other debtors

 

114

-

   

17,297

24,630

8

Creditors

Creditors: amounts falling due within one year

Note

2024
£

2023
£

Due within one year

 

Loans and borrowings

39,001

27,889

Trade creditors

 

45,446

36,995

Taxation and social security

 

43,435

32,538

Accruals and deferred income

 

18,549

2,321

Other creditors

 

2,778

8,848

 

149,209

108,591

There are two charges over the company at the year end date. The first from National Westminster Bank PLC was delivered 2nd February 2016 and is a fixed charge. The second again from National Westminster Bank PLC was delivered 29th February 2016 and is a fixed charge.

Creditors include net obligations under finance lease and hire purchase contracts which are secured of £39,001 (2023 - £27,889).

 

Washington Eyecare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

Creditors: amounts falling due after more than one year

Note

2024
£

2023
£

Due after one year

 

Loans and borrowings

152,013

190,255

Creditors include net obligations under finance lease and hire purchase contracts which are secured of £152,013 (2023 - £190,255).